MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up
1996

MHC Class I Antigens and Tumour-Infiltrating Leucocytes in Laryngeal Cancer

Sample size: 60 publication Evidence: low

Author Information

Author(s): F Esteban, M Redondo, M Delgado, F Garrido, F Ruiz-Cabello

Primary Institution: Hospital Universitario 'Virgen de Valme', Seville

Hypothesis

Does the presence or absence of HLA-A, -B, and -C antigens in laryngeal carcinoma influence survival?

Conclusion

Total loss of HLA-A, -B, and -C expression is not associated with a high risk of tumour-related death.

Supporting Evidence

  • Thirteen tumours presented total HLA-ABC loss, five selective losses of HLA-A antigens, and one absence of HLA-B antigens.
  • Total losses were statistically associated with several clinical and pathological parameters.
  • Follow-up ranged from 66 to 112 months, with 19 patients having died, 12 due to the disease.

Takeaway

This study looked at how certain proteins on cancer cells affect survival in laryngeal cancer, and found that losing these proteins doesn't seem to change how long patients live.

Methodology

The study evaluated 60 primary laryngeal tumours for MHC class I antigens and tumour-infiltrating leucocytes using monoclonal antibodies and the APAAP technique.

Limitations

The study's findings may not be generalizable due to the small sample size and lack of statistical significance in some results.

Participant Demographics

All participants were male, aged 44 to 75 years, with an average age of 58.68 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication